Kazumasa Fujitani

Kazumasa Fujitani

Auto-generated profile, based on publicly available information

Kazumasa Fujitani

Department of Surgery, Osaka Prefectural General Medical Center, Osaka, Japan

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2011
Verified
Journal Article
Closed access
HOHisataka Ogawa
Hisataka Ogawa
KFKazumasa Fujitani
Kazumasa Fujitani
TTToshimasa Tsujinaka
Toshimasa Tsujinaka
KIKenji Imanishi
Kenji Imanishi
HSHatsumi Shirakata
Hatsumi Shirakata
SUShigetoshi Utsumi
Shigetoshi Utsumi

16 August 2012 in Gastric Cancer
Verified
Journal Article
Closed access
PDF file
KFKazumasa Fujitani
Kazumasa Fujitani
IMIsao Miyashiro
Isao Miyashiro
SMShoki Mikata
Shoki Mikata
STShigeyuki Tamura
Shigeyuki Tamura
HIHiroshi Imamura
Hiroshi Imamura
YDYuichiro Doki
Yuichiro Doki

9 July 2008 in Japanese Journal of Clinical Oncology
Verified
Journal Article
Open access
PDF file
KFKazumasa Fujitani
Kazumasa Fujitani
HYHan-Kwang Yang
Han-Kwang Yang
YKYukinori Kurokawa
Yukinori Kurokawa
DPDo Joong Park
Do Joong Park
TTToshimasa Tsujinaka
Toshimasa Tsujinaka
FAfor the Gastric Cancer Surgical Study Group of Japan Clinical Oncology Group and Korea Gastric Cancer Association
for the Gastric Cancer Surgical Study Group of Japan Clinical Oncology Group and Korea Gastric Cancer Association
A randomized controlled trial has started in both Japan and Korea to evaluate the role of gastrectomy in the management of incurable advanced gastric cancer (AGC). Patients with AGC diagnosed as having a single non-curable factor are randomized to gastrectomy plus chemotherapy or chemotherapy alone. Surgeons at 33 specialized centers in Japan and at 15 high-volume hospitals in Korea will recruit 330 patients. Primary end-point is overall survival, and secondary end-points are progression-free survival and adverse events associated with either gastrectomy or chemotherapy.

1 July 2013 in Digestive Surgery
Verified
Journal Article
Open access
PDF file
KFKazumasa Fujitani
Kazumasa Fujitani
This review presents the current status of adjuvant and neoadjuvant treatment options for primary resectable gastric cancer in the East, with updated data from recent studies. Marked disparities between the East and the West in standard surgical procedures (D2 vs. D1/0 lymphadenectomy) and their outcomes result in significant geographical variation in preferred adjuvant treatments. Currently, oral fluoropyrimidine-based postoperative adjuvant chemotherapy, 1 year of S-1 chemotherapy, or capecitabine plus oxaliplatin for 6 months are the standards of care after curative resection with D2 lymphadenectomy for stage II/III gastric cancer in the East, though there is still some room for improvement. The role of postoperative adjuvant chemoradiotherapy (CRT) following curative D2 gastrectomy has long been debated in the East. However, the first prospective randomized controlled trial comparing CRT with chemotherapy alone failed to demonstrate a survival benefit, thus further studies are required. Chemotherapy has been pursued as a neoadjuvant approach in East Asia because of a rare locoregional recurrence after curative D2 gastrectomy. Locally advanced, marginally resectable gastric cancer with poor prognosis, such as large type 3 or 4 tumors, para-aortic and/or bulky nodal disease, and serosa-positive gastric cancer, is the main target of neoadjuvant chemotherapy. Promising efficacy has been demonstrated in several phase II studies with the safe use of D2 or more extended surgery following neoadjuvant chemotherapy. Although the results of ongoing phase III trials are awaited, Asian findings could be relevant and generalizable to other regions when D2 surgery is performed by experienced surgeons.

21 December 2011 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
KFKazumasa Fujitani
Kazumasa Fujitani
MMMasayuki Mano
Masayuki Mano
MHMotohiro Hirao
Motohiro Hirao
YKYoshinori Kodama
Yoshinori Kodama
TTToshimasa Tsujinaka
Toshimasa Tsujinaka

13 December 2006
Verified
Journal Article
Closed access
TMTomoki Makino
Tomoki Makino
TTToshimasa Tsujinaka
Toshimasa Tsujinaka
HMHideuki Mishima
Hideuki Mishima
MIMasakazu Ikenaga
Masakazu Ikenaga
TSToshiro Sawamura
Toshiro Sawamura
MMMasayuki Mano
Masayuki Mano